TrialJournal of neuro-oncology2006

Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status.

Morris D Groves et al.PubMed ↗Publisher ↗

No numbers read from the abstract.